Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Similar documents
Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Diagnosis and Management of Acute Myocardial Infarction

Chest Pain Accreditation ACS Education

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Results of Ischemic Heart Disease

Circulation and Cardiac Emergencies. Emergency Medical Response

Acute Myocardial Infarction

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT

Ischemic Heart Diseases. Dr. Nabila Hamdi MD, PhD

Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist

Acute Coronary Syndrome

Chest Pain. Dr. Amitesh Aggarwal. Department of Medicine

FastTest. You ve read the book now test yourself

Exhibit EP16.h University of Virginia Medical Center Clinical Decision Tool

Acute Coronary Syndrome. Sonny Achtchi, DO

2010 ACLS Guidelines. Primary goals of therapy for patients

Can be felt where an artery passes near the skin surface and over a

Pre Hospital and Initial Management of Acute Coronary Syndrome

Chapter 14 Cardiovascular Emergencies Cardiovascular Emergencies Cardiovascular disease has been leading killer of Americans since.

Acute coronary syndromes

Cardiac Pathology & Rehabilitation

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Acute Coronary Syndromes

Practitioner Education Course

Heart Disorders. Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8. Overview Heart Disorders Vascular Disorders

12 Lead EKG Chapter 4 Worksheet

Ischemic heart disease

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Cindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC

Cardiac Emergencies. A Review of Cardiac Compromise. Lawrence L. Lambert

Chest Pain. Dr Robert Huggett Consultant Cardiologist

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Cardiovascular Diseases and Diabetes

Common Codes for ICD-10

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection

Non ST Elevation-ACS. Michael W. Cammarata, MD

Cardiovascular and Respiratory Disorders

MYOCARDIALINFARCTION. By: Kendra Fischer

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Acute Myocardial Infarction. Acute Coronary Syndrome (ACS) No ST Elevation. ST Elevation

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

A Cardiologist s Guide to Love

Clinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka

Chapter 16 Cardiovascular Emergencies Cardiovascular Emergencies Cardiovascular disease has been leading killer of Americans since 1900.

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Myocardial Infarction

Heart Disease. Signs and Symptoms

Acute Coronary Syndrome

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

Acute Coronary Syndrome (ACS): Evidence Based Trends and Treatment

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Παύλος Στουγιάννος. Καρδιολόγος ΓΝΑ «Η ΕΛΠΙΣ»

Ischemic Heart Disease

Chapter 14. Cardiovascular Emergencies

New Guidelines for Evaluating Acute Coronary Syndrome

Myocardial infarction

Angina Luis Tulloch, MD 03/27/2012

TOPICS IN EMERGENCY MEDICINE SEMI-FINAL

MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient

12 Lead ECG Interpretation

APPENDIX F: CASE REPORT FORM

When the learner has completed this module, she/he will be able to:

LESSON ASSIGNMENT. LESSON 2 Heart Attack and Cardiopulmonary Resuscitation. After completing this lesson, you should be able to:

Cardiovascular Disease in Women over 50. Jessie Fazel, Kristin Jeschke, and Teresa Taylor. University of Kansas School of Nursing

ST Elevation Myocardial Infarction

Acute Coronary Syndrome- The Role of the ACS Clinic in Providing Best Practice Care

Management of Acute Myocardial Infarction

It is what you will see most in practice and what you need to know thoroughly.

Continuing Medical Education Post-Test

Cardiovascular Concerns in Intermediate Care

Pre-Operative Services Teaching Rounds 3 Jan 2011

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome

The Fundamentals of 12 Lead EKG. ECG Recording. J Point. Reviewing the Cardiac Conductive System. Dr. E. Joe Sasin, MD Rusty Powers, NRP

CORONARY ARTERY DISEASE OVERVIEW

Acute Coronary Syndrome including STEMI

HeartRescue Global Policy Brief STEMI: ST-segment elevation myocardial infarction. HeartRescue Global MEDTRONIC FOUNDATION

Acute Coronary syndrome

4. Which survey program does your facility use to get your program designated by the state?

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Coronary Artery Disease. Overview. Gary Ferenchick, MD. How Does CAD Present? Stable CAD Unstable CAD Angina MI

HEART DISEASE HEART CONDITIONS, RISKS AND PROTECTION

ST Elevation Myocardial Infarction

Cardiac Emergencies. Jim Bennett Paramedic and Clinical Education Coordinator American Medical Response Spokane, Washington

DISCUSSION QUESTION - 1

Heart failure congestive heart failure, or CHF

Acute Coronary Syndrome (ACS) Initial Evaluation and Management

2008, American Heart Association. All rights reserved.

Transcription:

10/2013 1

Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Purpose of this Education Module: Chest Pain Center Accreditation involves the management of chest pain anywhere in the hospital. Intensive Care and Step down Units along with Emergency Department staff care for many patients who have or are at a high risk for heart disease. Knowledge of ACS pathophysiology and early recognition is key to impacting patient outcomes. Early recognition reduces the time it takes for patients experiencing symptoms of possible ACS to see a physician thus decreasing the time to treatment which is critical in the early stages when treatment is most effective. September 2012 3

Background Coronary Artery Disease (CAD) = #1 killer of men and women in U.S. Affects about 12 million Americans In the US, CAD claims more lives each year than the next 7 leading causes of death combined! Myocardial Infarction (MI) or Heart attack 1.1 million people affected each year About half present at ED triage not using EMS 460,000 deaths annually from MI Half of these deaths occur before reaching hospital Estimated average number of years of life lost due to a heart attack is 14.2 Average delay in presentation about 3 hours from onset on symptoms! 10/2013 4

Acute Coronary Syndrome refers to a state of symptomatic ischemia or infarction resulting from a completely or partially clot-obstructed coronary artery. ST elevated MI (Complete occlusion) Non ST elevation MI (Partial occlusion) 10/2013 5

Cardiac Risk Factors Non-Modifiable Risk Factors Previous history Family history 1 st degree relative (parents, siblings) Men < 55; Women < 65 Age Gender Socioeconomic Factors and Ethnicity 9 easily measured and potentially modifiable risk factors account for over 90% of the risk of an initial acute MI Smoking Hypertension Dyslipidemia Diabetes Obesity Metabolic Syndrome Inactivity Alcohol 10/2013 6

Assessment of Pain Linking Patient History and Risk factors Cardiac Biomarkers ECG Findings 10/2013 7

Assessment of cardiac pain N = Normal (What is the patient s baseline?) O = Onset (sudden/gradual?) P = Precipitation / provoking / palliative factors Q = Quality or quantity (have patient describe in own words) R = Radiation and region S = Severity (pain scale) T = Time (continuous/intermittent?) 10/9/2013 8

ACS Symptoms Classic Symptoms Symptom Variations Stable angina Unstable angina MI Women Elderly Diabetics 10/9/2013 9

Angina Stable Occurs with physical exertion or emotional stress Relieved by rest or sublingual nitroglycerin Predictable pattern Predictable = triggered by the same amount of physical or emotional stress and should be easily relieved by rest or sublingual nitroglycerin. Unstable Occurs with minimal exertion OR increased dose of nitroglycerin is required to achieve relief. Prolonged rest angina is also considered unstable angina. Angina that increases in severity or is very severe on first presentation Caused by unstable or ruptured plaque that causes abrupt closure of a coronary artery which may spontaneously reperfuse. 10/2013 10

Characteristics of Angina Sensation of pressure, tightness, heaviness, burning, or squeezing. Rarely described as a sharp or stabbing pain. Should not worsen with changes in position or respiration. Location behind the sternum and in the upper back, shoulder, arm, jaw, or epigastric area. Not usually located in the middle to lower abdomen and usually does not radiate to the lower extremities. Associated symptoms (or stand alone symptoms) of dyspnea, nausea, palpitations, or diaphoresis. Duration typically defined in minutes. Not typically defined in seconds or hours. CAUTION WHEN ASKING THE PATIENT ABOUT PAIN! May deny pain but may state pressure, fullness or heaviness. 10/2013 11

Symptoms in Special Populations ACS in Women Delay presenting with symptoms Attribute symptoms to other non-cardiac causes Presentation epigastric discomfort less specific complaints: dyspnea or fatigue symptoms of discomfort from nose to navel should be evaluated for presence of heart disease Older women have higher incidence of complications ACS in the Elderly Generalized symptoms Dyspnea, diaphoresis, N&V, and syncope Confusion Symptoms often attributed to the aging process such as activity intolerance ACS in the Diabetic Patient Autonomic dysfunction can affect symptoms experienced with angina Less likely to experience pain. 25% of all patients presenting with ACS are diabetic Have severe multi-vessel disease Have higher rates of complications Have a greater proportion of ulcerated plaques resulting in intracoronary thrombi 10/2013 12

Cardiac Biomarkers Released into the blood when necrosis occurs as a result of membrane rupture of the myocytes Used in the evaluation of ACS Myoglobin Rises the earliest Within 2 hours after damage Very sensitive, not specific CK (creatine kinase) Enzyme present in the heart, brain, and skeletal muscle Elevations are not specific to myocardial damage. CK-MB More specific to the heart Helpful in identifying more than minor amounts of myocardial damage Rapidly rises in the presence of myocardial damage. 10/2013 13

Cardiac Biomarkers Troponin I and T Found only in cardiac muscle Most sensitive indicator of myocardial damage Capable of diagnosing small amounts of myocardial necrosis not measured by rises in CK-MB levels Approximately 30% of patients with NSTEMI and normal CKMB levels will test positive Of equal sensitivity and specificity Troponin remains elevated for a long period (late presentation) Positive troponin + ECG changes of injury / ischemia = infarct Non CAD causes of troponin elevation (sepsis, pulmonary emboli and chronic kidney disease) Troponin I more specific in renal dysfunction 10/2013 14

Cardiac Biomarker Summary Cardiac Biomarker Specificity / Sensitivity Rise Peak Duration Myoglobin Sensitive but not specific Within 2 hours 4 to 10 hours < 24 hours CK-MB (more specific to the heart than CK levels) Highly specific 4 to 6 hours 18 to 24 hours 2 to 3 days Troponin I or T Highly specific and sensitive 4 to 6 hours 18 to 24 hours 10 or more days 10/2013 15

ECG Findings A discussion of injury/ischemia ECG findings is beyond the scope of this module. Key tips Mark chart copy as pain free or with pain on top of ECG ECG Critical Values at Aultman include the following and require physician notification Acute MI Bradycardia <45 beats Ventricular Tachycardia 10/2013 16

STAT ECG Indications Chest pain or severe epigastric pain, non traumatic in origin, with components typical of myocardial ischemia or MI: Central/substernal compression or crushing chest pain Pressure, tightness, heaviness, cramping, burning, aching sensation Unexplained indigestion, belching, epigastric pain Radiating pain in neck, jaw, shoulders, back, or 1 or both arms If non diagnostic: Associated dyspnea Associated nausea/vomiting Repeat every 15 to 30 minutes Associated diaphoresis Use ST segment monitoring Consider right-sided/posterior ECG 10/2013 17

SCREEN for ACS if > 30 years old with any of the following: Chest discomfort of any kind Heartburn, indigestion, or epigastric pain Complaints of heart racing (HR >150 or irregular and >120) Complaints of heart too slow (HR < 50 and symptomatic) Syncopal episode or severe weakness in patients > 45 years old Difficulty breathing (no obvious non cardiac cause) </= 30 with any of the above PLUS: Prior Cardiac disease Family history of early heart disease Diabetes mellitus Severe Obesity Recent cocaine use Remember: Women and diabetic patients are more likely to present with atypical symptoms When in doubt, do the ECG! Elderly patients may have symptoms such as generalized weakness, altered mental status, shortness of breath, or syncope, as their only sign of acute heart attack. 10/2013 18

< 25% of ACS patients Complete occlusion of a vessel by a thrombus Fibrin stable clot (red clot) Classified more specifically by the portion of the left ventricle suffering injury. Mortality is greatest within the first 24 to 48 hours of symptom onset TREATMENT FOCUS = REPERFUSION 10/2013 19

Acute MI Symptoms Symptoms occur spontaneously and are not relieved by rest or nitroglycerin Chest pressure or discomfort may be accompanied by nausea, vomiting, or diaphoresis Patient may have hemodynamic instability or cardiac arrest from ventricular fibrillation Acute MI patients have positive biomarkers and are classified as STEMI or NSTEMI based on ECG presentation 10/2013 20

STEMI Management Reperfusion is number one treatment strategy Primary Coronary Intervention (PCI) preferred treatment strategy if within 90 minutes Goal: 90 minutes from 1 st medical contact Fibrinolytics within 30 minutes of hospital presentation (or 30 minutes from EMS to fibrinolytics) Facilitated PCI with full dose fibrinolytics is not recommended. Rescue PCI may be done after failed fibrinolytics 10/2013 21

Reperfusion Therapy Fibrinolytic Therapy Primary PCI The Winner! Primary PCI has clear outcome advantage in those > 65 years: Mortality Stroke Intracranial Hemorrhage Reperfusion has proven benefit up to age 85. 10/2013 22

Medical Management of STEMI ASA Clopidogrel (with or without reperfusion) Oxygen NTG MS D/C NSAIDS Beta-blockers (within 24 hours) Reperfusion is primary management strategy. ACE Inhibitors (within 24 hours with impaired EF, HTN, diabetes or chronic kidney disease) Anticoagulants (related to reperfusion strategy) Intravenous insulin may be indicated in first 24 to 48 hours after STEMI to tightly control blood sugars. 10/2013 23

Treatment of NSTEMI / UA: New Guidelines ASA Oxygen (1 st 6 hours) NTG Medical Supportive Therapy: Similar to STEMI IV in first 48 hours for persistent ischemia, HTN, HF Should not interfere with mortality reducing beta blockers or ace inhibitors MS (if NTG unsuccessful and other anti ischemic drugs on board ) Beta Blockers (within 24 hours) Start PO when hemodynamically stable May use IV if hypertensive ACE Inhibitors (within 24 hours) In select patients pulmonary congestion or LVEF < 40%) may also be used in other patients DC NSAIDS 10/2013 24

Complications of MI Hemodynamic Alterations Ventricular Arrhythmias Atrial Arrhythmias Pericarditis Ventricular Aneurysms Mechanical Complications Myocardial Rupture (free wall or VSD) Papillary Muscle Rupture Long Term: Ventricular Remodeling 10/2013 25

New addition to all admission power plans In order to improve our patient care for an In house STEMI patient a communication order will be added to each admission power plan. This order is prechecked and states Stat ECG will be obtained in the setting of a Rapid Response for suspected heart attack signs or symptoms This will allow the rapid response team to immediately obtain an ECG allowing quicker diagnosis and STEMI alert will be called if ECG is diagnostic for STEMI. 10/2013 26

Information that needs charted with In House STEMI patient Onset of symptoms EKG time Notification of physician Time STEMI called Departed from floor ( to either Heart Cath lab or CCU) It is important to accurately chart the times the above occurs. Use IP phone or computer for atomic time. Atomic time is a synchronized time and is very important when tracking quality data. This patient may be in three different locations during this quality data collection and each area using this atomic time will allow accurate data collection. This data will be tracked and used as quality data to improve our care for the In house STEMI patient. 10/2013 27

Summary Remember, time is muscle! Save hearts and lives by knowing the signs/symptoms of ACS Activate the rapid response team and notify the physician Obtain an EKG 10/2013 28